U.S. Wireless Telecom Stock News

On November 12, 2025, Anterix and Crown Castle jointly announced the launch of Anterix TowerX, a turnkey service designed to accelerate and optimize the deployment of 900 MHz private LTE networks for utilities across the U.S., leveraging Crown Castle’s network of more than 40,000 tower sites. This collaboration not only streamlines wireless infrastructure projects for the utility sector but also highlights Crown Castle’s deeper integration into nationwide critical infrastructure...

Navitas Semiconductor recently closed a US$100 million private placement, issuing over 14.8 million new shares to accredited investors, with capital earmarked to fund expansion initiatives in high-power markets including AI data centers and industrial electrification. This move comes as Navitas pursues a business transition under newly appointed CEO Chris Allexandre, including a shift away from lower-margin consumer and mobile segments and the announcement of a high-profile partnership to...

On November 12, 2025, Insight Enterprises announced the launch of Insight AI, a comprehensive suite of services designed to help organizations overcome common barriers to AI adoption using pragmatic roadmaps, expert tools, and delivery accelerators. This new offering integrates Insight's recent acquisitions and its own internal AI expertise to provide clients with clear value realization and reduced risk in enterprise AI initiatives. We will explore how Insight AI's promise of faster,...

Eversource Energy recently reported third quarter and nine-month 2025 earnings, showing higher sales at US$3.22 billion and strong profitability, turning around from a net loss a year earlier. The company also reaffirmed its full-year and long-term earnings guidance, indicating confidence in the underlying strength of its core utility business and future earnings outlook. With quarterly net income rebounding sharply, we'll explore how this performance supports the company's investment...

CVS Health (CVS) stock is getting more attention as the company sharpens its focus on profitable areas and deepens its reach into pharmacy care. The acquisition of prescription files from Rite Aid and Bartell Drugs, along with improved financial results, is turning heads among investors. See our latest analysis for CVS Health. This year’s headline-grabbing moves from CVS Health, including the Rite Aid file acquisition and a focus on core profits, have clearly resonated with investors as...

Earlier this month, Coty Inc. filed a lawsuit in the UK against Kering and Gucci over the planned transfer of the Gucci beauty and fragrance license to L'Oréal, with all parties confirming the current license will remain in effect until expiration in 2028. This legal dispute brings fresh uncertainty to Coty's operations and future licensed brand revenues, as it unfolds alongside recent earnings pressures and leadership changes. We'll explore how the pending Gucci license litigation could...

Lam Research (LRCX) recently saw its stock gain attention after analysts revised earnings estimates higher, resulting in a consensus rating between Strong Buy and Buy. This wave of renewed optimism has highlighted its near-term prospects for investors. See our latest analysis for Lam Research. Lam Research’s momentum has been building, with analyst optimism and solid earnings sentiment helping drive a 30-day share price return of 17.1% and an eye-catching 122.8% year-to-date gain. Even as...

BKV (BKV) reported its third quarter results, showing a significant jump in both revenue and net income compared to last year. The company also shared plans to increase its stake in a power joint venture and move forward with carbon capture projects. See our latest analysis for BKV. BKV’s strong earnings growth and renewed push into power and carbon capture have drawn plenty of market buzz, with the share price jumping 27% over the last 30 days. Momentum appears to be building as investors...

Newmark Group (NMRK) just reported strong third-quarter results, with both revenue and net income climbing well above last year. The company also revised its 2025 revenue guidance upward and is projecting roughly 18% growth at the midpoint. See our latest analysis for Newmark Group. It’s been an eventful year for Newmark Group, with headline earnings growth followed by fresh appointments to its European Finance team and high-profile conference appearances that signal a company on the move...

GXO Logistics (GXO) just posted its third-quarter results, revealing higher sales and net income compared to last year. The company also reconfirmed its full-year outlook for organic revenue growth. These latest moves are drawing fresh investor interest. See our latest analysis for GXO Logistics. Momentum has started to return for GXO Logistics as recent quarterly results and new leadership have boosted confidence, even after a tough period that saw rising costs and a valuation downgrade. The...

CrowdStrike Holdings (CRWD) shares are drawing attention after the company revealed a strategic partnership with F5 to integrate its Falcon Sensor and OverWatch Threat Hunting with F5’s BIG-IP platforms. This move extends CrowdStrike’s reach to the network edge. See our latest analysis for CrowdStrike Holdings. CrowdStrike’s string of partnerships and product launches, from expanded AI-driven integrations with CoreWeave to bringing Falcon capabilities to F5’s BIG-IP, has kept momentum firmly...

LKQ Corporation recently reported its third-quarter 2025 earnings, updated its full-year guidance, declared a US$0.30 dividend, and announced the upcoming departure of Director Jody G. Miller, while also completing a significant share buyback program totaling over US$2.9 billion. The company has sustained service and inventory levels despite declining repairable claims, emphasizing its ongoing multi-year operational transformation and maintaining investor focus on margin improvement and...

Magnite (MGNI) saw its shares move after posting impressive quarterly results, with higher revenue and profit compared to last year. The company also introduced new product enhancements and strengthened partnerships across the connected TV and programmatic ad space. See our latest analysis for Magnite. Despite robust quarterly earnings and headline product partnerships, Magnite’s recent 30-day share price return of -18.8% and a sharp 90-day drop of nearly 40% highlight the volatility tech...

In the past week, Waste Connections reported third quarter revenue that topped expectations, while adjusted earnings per share missed forecasts, and announced an 11.1% rise in its quarterly dividend alongside share buybacks equal to about 1% of its shares. The company also disclosed that year-to-date, it has completed or secured formal agreements on acquisitions totalling approximately US$300 million in annual revenue. Alongside updated financial results, Waste Connections is highlighting...

Zymeworks Inc. recently reported a reduced net loss of US$19.6 million for the third quarter of 2025, began a Phase I trial for a new ADC candidate, and completed a substantial share buyback program, all alongside board changes. The company’s encouraging clinical progress, improved financials, and ongoing partnerships highlight renewed momentum in its oncology pipeline and capital management. We’ll explore how positive initial Phase I results for ZW191 contribute to shifting Zymeworks’...

Earlier this month, CareTrust REIT reported third quarter 2025 results, highlighting a very large increase in revenue and net income year-over-year, and updated its unaudited full-year 2025 earnings guidance to a range of US$1.41 to US$1.42 per diluted share. This performance underscores the effects of recent acquisitions and portfolio expansion, resulting in pronounced operational growth and higher expected earnings for the year. We will examine how these robust third quarter results and...

CRISPR Therapeutics (NasdaqGM:CRSP) drew investor attention after unveiling early data from its Phase 1 CTX310 trial. The results revealed strong, lasting reductions in cardiovascular risk factors and a safety profile that supports ongoing development. See our latest analysis for CRISPR Therapeutics. Despite the buzz around CRISPR Therapeutics’ positive CTX310 trial results and solid progress in its gene-editing pipeline, the share price has pulled back sharply this month, down 23.6% in the...

Sunoco LP reported its third quarter 2025 earnings in early November, revealing sales of US$6.03 billion and net income of US$137 million, both markedly higher than the same quarter last year. This turnaround saw the company swing to a profit per share versus a loss in the prior-year quarter, despite a weaker showing across the year-to-date period. We'll explore how Sunoco's sharp rebound in quarterly profitability could influence its longer-term investment narrative and outlook. Rare earth...

Airbnb (ABNB) shared new financial updates that give investors more clarity on the company’s momentum. The latest third quarter results highlighted steady revenue growth, along with guidance suggesting further expansion in the final quarter of the year. See our latest analysis for Airbnb. After announcing another quarter of steady growth and completing a significant buyback, Airbnb's share price has been mostly steady this year. The latest revenue guidance hints at renewed momentum ahead...

Delta Air Lines (DAL) stock has seen a bit of movement lately, with investors keeping a close eye on its recent performance. Over the past month, shares are up about 3%, while the past 3 months have added just over 2%. See our latest analysis for Delta Air Lines. After lagging for much of the year, Delta’s 1-year total shareholder return is still down around 5%, but renewed optimism and a strong 1-day share price jump suggest momentum could finally be shifting for the airline as travel demand...

Wondering if Bristol-Myers Squibb is currently undervalued or just flying under the radar? You are not alone; plenty of curious investors are trying to gauge what this moment means for the stock's long-term potential. After several months of declines, Bristol-Myers Squibb shares have bounced 5.6% over the last week and 12.7% over the past month. This hints at renewed interest or shifting market perceptions. Recently, headlines around new drug approvals and speculation about potential mergers...

Roivant Sciences (ROIV) shares traded actively following its recent earnings announcement. The report showed a reduced net loss compared to last year amid lower sales. Investors also took note of positive Phase 3 clinical results and legal developments. See our latest analysis for Roivant Sciences. Roivant Sciences’ mix of narrowing losses and pipeline wins appears to have shifted sentiment, as shown by a 31.5% share price return over the past month and an impressive 81.5% return over the...

Blue Owl Capital (NYSE:OWL) just revealed a $3 billion investment in a New Mexico data center supporting OpenAI’s Stargate AI project. This move signals Blue Owl’s drive to increase its footprint in technology and digital infrastructure. See our latest analysis for Blue Owl Capital. Blue Owl’s $3 billion push into AI infrastructure arrives on the heels of several notable moves, including a new home equity securitization and a fresh quarterly dividend. Despite this momentum, the stock’s share...

CoreCivic (CXW) has been navigating a challenging stretch, with the stock slipping 8% in the past week and posting a decline of 17% over the past 3 months. Despite recent pressure, the company’s annual revenue and net income growth remain in positive territory. See our latest analysis for CoreCivic. CoreCivic’s share price has struggled to gain traction lately, retreating over the past three months and leading to a 21% decline year-to-date. Despite the recent negative momentum, the company...